MLi-2 |
Inhibitor of LRRK2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| LRRK2 |
|
|
Inhibitor
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50
Potency Assay Off-Target:
KinomeScan
Selectivity Assessment Description:
> 100-fold kinome selective with IC50 < 1 µM for the following kinases: CLK4 (225 nM), MAP3 ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
PanLabs Profiling
Selectivity Assessment Description:
PanLabs Profile shows 5 hits > 50% inhibition (@ 10 μM): HTR2B (1.2 µM), SLC6A2 (3.8 µM), CHRM ...
Potency Cellular
In Vitro
LRRK2
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
In Vivo Validations
Mouse, Rat
Dose: 30 mg/Kg Oral, 2 mg/Kg IV
Route of delivery:
Intravenous, Oral
Organ of interest (O):
Brain
Reference: --
Negative Control Compounds
MLi-2-NC
Orthogonal Probes def
GNE7915
Chemical Information
| Molecular Formula | C21H25N5O2 |
| SMILEs | C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1 |
| InChI | InChI=1S/C21H25N5O2/c1-13-10-26(11-14(2)27-13)19-9-18(22-12-23-19)20-16-8-15(28-21(3)6-7-21)4-5-17(16)24-25-20/h4-5,8-9,12-14H,6-7,10-11H2,1-3H3,(H,24,25)/t13-,14+ |
| Molecular weight | 379.20 Da |
| AlogP | 3.5648000000000026 |
| HBond acceptors | 7 |
| HBond donors | 1 |
| Atoms | 53 |